Selumetinib in Treating Patients With Biliary Cancer That Cannot Be Removed By Surgery

Clinical trial NCT00553332 · COMPLETED

Trial details

NCT number: NCT00553332
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Liver and Intrahepatic Biliary Tract Cancer Recurrent Extrahepatic Bile Duct Cancer Unresectable Extrahepatic Bile Duct Cancer

Start date: 2007-11-01
Primary completion: 2013-01-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.